130 related articles for article (PubMed ID: 15660281)
1. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.
Kuroda H; Tamaru J; Sakamoto G; Ohnisi K; Itoyama S
Virchows Arch; 2005 Jan; 446(1):10-4. PubMed ID: 15660281
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB
Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Tamiolakis D; Simopoulos C; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Papadopoulos N
Eur J Gynaecol Oncol; 2002; 23(5):433-6. PubMed ID: 12440819
[TBL] [Abstract][Full Text] [Related]
5. Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.
Lim KH; Telisinghe PU; Abdullah MS; Ramasamy R
Cancer Immun; 2010 Jan; 10():3. PubMed ID: 20092246
[TBL] [Abstract][Full Text] [Related]
6. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast.
Guo X; Fan Y; Lang R; Gu F; Chen L; Cui L; Pringle GA; Zhang X; Fu L
Mod Pathol; 2008 Sep; 21(9):1101-7. PubMed ID: 18469794
[TBL] [Abstract][Full Text] [Related]
7. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
[TBL] [Abstract][Full Text] [Related]
8. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
Nurlaila I; Telisinghe PU; Ramasamy R
Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
[TBL] [Abstract][Full Text] [Related]
9. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
11. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Breast Cancer: an Immunomorphological Update.
Roncati L; Barbolini G; Piacentini F; Piscioli F; Pusiol T; Maiorana A
Pathol Oncol Res; 2016 Jul; 22(3):449-52. PubMed ID: 26589512
[TBL] [Abstract][Full Text] [Related]
15. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
16. Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes.
Kotlan B; Simsa P; Teillaud JL; Fridman WH; Toth J; McKnight M; Glassy MC
J Immunol; 2005 Aug; 175(4):2278-85. PubMed ID: 16081796
[TBL] [Abstract][Full Text] [Related]
17. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.
Hansen MH; Nielsen H; Ditzel HJ
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12659-64. PubMed ID: 11606714
[TBL] [Abstract][Full Text] [Related]
18. Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus.
Gross T; Wagner A; Ugurel S; Tilgen W; Reinhold U
Dermatology; 2001; 202(3):198-202. PubMed ID: 11385223
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.
Mani NL; Schalper KA; Hatzis C; Saglam O; Tavassoli F; Butler M; Chagpar AB; Pusztai L; Rimm DL
Breast Cancer Res; 2016 Jul; 18(1):78. PubMed ID: 27473061
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.
Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S
Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
